Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis.
Ann Rheum Dis
; 80(3): 406-408, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-32843325
Full text:
1
Database:
MEDLINE
Main subject:
Azetidines
/
Dermatomyositis
Limits:
Humans
Language:
En
Journal:
Ann Rheum Dis
Year:
2021
Type:
Article
Affiliation country:
United States